These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1920325)
1. Clinical trials in rheumatoid arthritis under attack: are practice based observational studies the answer? Felson DT J Rheumatol; 1991 Jul; 18(7):951-3. PubMed ID: 1920325 [No Abstract] [Full Text] [Related]
2. Design and analysis of a randomized controlled trial testing the effects of clinical decision support on the management of rheumatoid arthritis. Fransen J; Twisk JW; Creemers MC; van Riel PL Arthritis Rheum; 2004 Feb; 51(1):124-7. PubMed ID: 14872465 [No Abstract] [Full Text] [Related]
3. Can observational studies replace or complement experiment? van der Linden S; Goldsmith CH; Woodcock J; Nassonova V J Rheumatol Suppl; 1994 Sep; 41():57-61. PubMed ID: 7799388 [TBL] [Abstract][Full Text] [Related]
4. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness. Wolfe F; Michaud K Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476 [TBL] [Abstract][Full Text] [Related]
5. Evaluating severity and status in rheumatoid arthritis. Wolfe F; O'Dell JR; Kavanaugh A; Wilske K; Pincus T J Rheumatol; 2001 Jun; 28(6):1453-62. PubMed ID: 11409143 [TBL] [Abstract][Full Text] [Related]
6. [The limits of controlled clinical studies: the case of rheumatology]. Portioli I Ann Ital Med Int; 2000; 15(1):39-46. PubMed ID: 10842890 [TBL] [Abstract][Full Text] [Related]
7. Proposed guidelines for the clinical evaluation of interleukin-1 inhibitors in the treatment of rheumatoid arthritis. Dougados M Eur Cytokine Netw; 1990; 1(4):235-7. PubMed ID: 2151768 [TBL] [Abstract][Full Text] [Related]
8. Structural characterization of rheumatoid arthritis by MRI: applications in clinical research and in clinical practice. Peterfy C J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):360-1. PubMed ID: 15758259 [No Abstract] [Full Text] [Related]
9. What have we learnt from early rheumatoid arthritis cohorts? Young A Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):3-12. PubMed ID: 19233041 [TBL] [Abstract][Full Text] [Related]
10. [Structured assessment of the treatment of rheumatoid arthritis]. Lindblad S; Svensson B Nord Med; 1994; 109(8-9):230, 235. PubMed ID: 7937031 [TBL] [Abstract][Full Text] [Related]
11. Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials. Strand V; Scott DL; Panayi GS J Rheumatol; 1994 Aug; 21(8):1390-2. PubMed ID: 7983635 [No Abstract] [Full Text] [Related]
12. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis. Farahani P; Levine M; Gaebel K; Thabane L Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497 [TBL] [Abstract][Full Text] [Related]
13. Quality of life in rheumatoid arthritis. Kvien TK; Uhlig T Scand J Rheumatol; 2005; 34(5):333-41. PubMed ID: 16234180 [TBL] [Abstract][Full Text] [Related]
14. On: Bernateck M, Becker M, Schwake C, Hoy L, Passie T, Parlesak A, Fischer MJ, Fink M, Karst M: Adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Forsch Komplementmed 2008;15:187-193. Ernst E Forsch Komplementmed; 2008 Oct; 15(5):286; author reply 286. PubMed ID: 19009726 [No Abstract] [Full Text] [Related]
15. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Pincus T; Sokka T Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii32-ii39. PubMed ID: 15479869 [TBL] [Abstract][Full Text] [Related]
16. Assessing the safety of biologic therapies in rheumatoid arthritis: the challenges of study design. Hyrich KL J Rheumatol Suppl; 2005 Jan; 72():48-50. PubMed ID: 15660468 [TBL] [Abstract][Full Text] [Related]
17. Treatment of severe rheumatoid arthritis. Lorenzen I Ann Clin Res; 1983 Apr; 15(2):80-7. PubMed ID: 6349514 [TBL] [Abstract][Full Text] [Related]
18. Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritis. Nixon RM; Bansback N; Stevens JW; Brennan A; Madan J Pharm Stat; 2009; 8(2):150-62. PubMed ID: 18942777 [TBL] [Abstract][Full Text] [Related]